摘要
<jats:title>Key Points</jats:title> <jats:p>Ibrutinib induces a rapid, dramatic, and sustained response in MCL patient with symptomatic CNS relapse. Ibrutinib penetration through the blood-brain barrier was confirmed using plasma and cerebrospinal fluid pharmacokinetic analyses.</jats:p>
- 出版日期2015-10-1
- 单位常州工学院